EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Omission of postoperative radiotherapy after breast-conserving surgery in low-risk breast cancer

Sofia Palmér iD, Antonis Valachis iD, Henrik Lindman iD, Daniel Robert Smith iD, Åsa Wickberg iD, Fredrika Killander, Judith Bjöhle, Zakaria Einbeigi iD, Greger Nilsson, Johan Ahlgren, Kenneth Villman

JNCI: Journal of the National Cancer Institute · 2025

DOI: 10.1093/jnci/djae315 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2025. Verfasst von Sofia Palmér und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Faculty of Medicine and Health, Örebro University Hospital, Örebro University, Örebro SE-70182, Sweden. Hauptthemen laut MEDLINE: Breast Neoplasms, Mastectomy, Segmental. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Local Research Committee, Örebro University Hospital, Key Foundation, Örebro University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This prospective cohort study aimed to assess whether postoperative radiotherapy could safely be omitted in women aged 65 years and older with low-risk, estrogen receptor–positive T1N0 breast cancer treated with breast-conserving surgery and adjuvant endocrine therapy.

Methods

Eligible patients were women aged 65 years and older with unifocal, nonlobular, grade 1 or 2, estrogen receptor–positive, pT1N0 breast cancer treated with breast-conserving surgery and endocrine therapy for 5 years. Patients were followed up with mammography at least annually for 10 years. The primary endpoint was local recurrence. Secondary endpoints were contralateral breast cancer, recurrence-free survival, and overall survival.

Results

The final study cohort included 601 patients with a median age of 71 years (range = 65-90 years) and a median tumor size of 11 mm (range = 3-20 mm). Median follow-up time was 119 months (interquartile range = 103-121 months). The cumulative incidence of local recurrence was 1.5% (95% confidence interval [CI] = 0.8% to 2.8%) and 5.5% (95% CI = 3.8% to 7.6%) at 5 and 10 years, respectively. The cumulative incidence of contralateral breast cancer was 1.7% (95% CI = 0.9% to 3.0%) at 5 years and 4.5% (95% CI = 3.0% to 6.6%) at 10 years. The overall survival rate at 10 years was 83.1% (95% CI = 80.8% to 85.4%). In total, 3 (0.5%) patients died because of breast cancer.

Conclusion

Our results support the possibility to omit radiotherapy after breast-conserving surgery in a well-defined subgroup of women aged 65 years and older with low-risk, estrogen receptor–positive, pT1N0 breast cancer receiving adjuvant endocrine therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMastectomy, SegmentalHumansFemaleAgedAged, 80 and overProspective StudiesNeoplasm Recurrence, LocalRadiotherapy, AdjuvantReceptors, EstrogenFollow-Up StudiesAntineoplastic Agents, HormonalNeoplasm StagingDisease-Free SurvivalRisk FactorsChemotherapy, Adjuvant

Substanzen

Receptors, EstrogenAntineoplastic Agents, Hormonal

Autor:innen und Institutionen

  • Department of Oncology, Faculty of Medicine and Health, Örebro University Hospital, Örebro University, Örebro SE-70182, Sweden.
  • Department of Oncology, Uppsala University Hospital, Uppsala 751 85, Sweden.
  • Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro 701 82, Sweden.
  • Department of Surgery, Faculty of Medicine and Health, Örebro University, Örebro 701 82, Sweden.
  • Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Skåne University Hospital, Lund University, Lund 221 85, Sweden.
  • Breast Center, Theme Cancer, Karolinska University Hospital and Karolinska Comprehensive Cancer Center, Stockholm 169 70, Sweden.

ORCID-Profile: Sofia Palmér, Antonis Valachis, Henrik Lindman, Daniel Robert Smith, Åsa Wickberg, Zakaria Einbeigi

Förderung

  • The Local Research Committee, Örebro University Hospital
  • Key Foundation, Örebro University Hospital

Zitieren

APA

Palmér, S., Valachis, A., Lindman, H., Smith, D. R., Wickberg, Å., Killander, F., Bjöhle, J., Einbeigi, Z., Nilsson, G., Ahlgren, J., & Villman, K. (2025). Omission of postoperative radiotherapy after breast-conserving surgery in low-risk breast cancer. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae315

Vancouver

Palmér S, Valachis A, Lindman H, Smith DR, Wickberg Å, Killander F, et al. Omission of postoperative radiotherapy after breast-conserving surgery in low-risk breast cancer. JNCI: Journal of the National Cancer Institute. 2025. doi:10.1093/jnci/djae315

BibTeX
@article{Palmr2025,
  author = {Palmér, Sofia and Valachis, Antonis and Lindman, Henrik and Smith, Daniel Robert and Wickberg, Åsa and Killander, Fredrika and Bjöhle, Judith and Einbeigi, Zakaria and Nilsson, Greger and Ahlgren, Johan and Villman, Kenneth},
  title = {Omission of postoperative radiotherapy after breast-conserving surgery in low-risk breast cancer},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2025},
  doi = {10.1093/jnci/djae315}
}
Kostenlos starten →